Congenic mapping and candidate sequencing of susceptibility genes for type 1 diabetes in the NOD mouse

Annals of the New York Academy of Sciences

Volumn 1005, Issue , 2003, Pages 196-204

  Ikegami, Hiroshi ^a,b   Fujisawa, Tomomi ^a   Makino, Susumu ^a   Ogihara, Toshio ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Interleukin 2; Interleukin 21; Major histocompatibility complex (MHC); NOD mouse; Susceptibility gene; Type 1 diabetes

Indexed keywords

ALLELE; CONFERENCE PAPER; CONGENIC STRAIN; EXPERIMENTAL MODEL; GENE IDENTIFICATION; GENE LOCATION; GENE MAPPING; GENE MUTATION; GENE SEQUENCE; GENETIC SUSCEPTIBILITY; HAPLOTYPE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE STRAIN; NONHUMAN; PHENOTYPE;

ANIMALIA;

EID: 1942475135     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1288.026     Document Type: Conference Paper

References (34)

1. HATTORI, M., J. BUSE, R. JACKSON et al. 1986. The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex. Science 231: 733-735.
2. WICKER, L.S., B.J. MILLER, L.Z. COKER et al. 1987. Genetic control of diabetes and insulitis in the nonobese diabetic (NOD) mouse. J. Exp. Med. 165: 1639-1654.
3. PROCHAZKA, M., D. SERREZE, S. WORTHEN et al. 1989. Genetic control of diabetogenesis in NOD/Lt mice: development and analysis of congenic stocks. Diabetes 38: 1446-1455.
4. WICKER, L., M. APPEL, F. DOTTA et al. 1992. Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice: the NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetes. J. Exp. Med. 176: 67-77.
5. + nonobese diabetic mice develop insulitis and diabetes. J. Exp. Med. 178: 793-803.
6. IKEGAMI, H. & S. MAKINO. 1993. Genetic susceptibility to insulin-dependent diabetes mellitus: from NOD mice to humans. In Lessons from Animal Diabetes IV, pp. 39-50. Smith-Gordon. London.
7. IKEGAMI, H., S. MAKINO & T. OGIHARA. 1996. Molecular genetics of insulin-dependent diabetes mellitus: analysis of congenic strains. In Lessons from Animal Diabetes VI, pp. 33-46. Birkhauser. Boston
8. WICKER, L., J. TODD & L. PETERSON. 1995. Genetic control of autoimmune diabetes in the NOD mouse. Annu. Rev. Immunol. 13: 179-200.
9. IKEGAMI, H., S. MAKINO, M. HARADA et al. 1988. The cataract Shionogi mouse, a sister strain of the nonobese diabetic mouse: similar class II, but different class I gene products. Diabetologia 31: 254-258.
10. IKEGAMI, H., G. EISENBARTH & M. HATTORI. 1990. Major histocompatibility complex-linked diabetogenic gene of the nonobese diabetic mouse: analysis of genomic DNA amplified by the polymerase chain reaction. J. Clin. Invest. 85: 18-24
11. IKEGAMI, H., Y. KAWAGUCHI, H. UEDA et al. 1993. MHC-linked diabetogenic gene of the NOD mouse: molecular mapping of the 3′ boundary of the diabetogenic region. Biochem. Biophys. Res. Commun. 192: 677-682.
12. IKEGAMI, H., S. MAKING & E. YAMATO. 1995. Identification of a new susceptibility locus for insulin-dependent diabetes mellitus by ancestral haplotype congenic mapping. J. Clin. Invest. 96: 1936-1942.
13. BABAYA, N., H. IKEGAMI, Y. KAWAGUCHI et al. 2000. Congenic mapping and functional analysis of a second component of the MHC-linked diabetogenic gene (Idd16). Int. J. Diabetes 8: 1-7.
14. HATTORI, M., E. YAMATO, N. ITOH et al. 1999. Homologous recombination of the MHC class I K region defines new MHC-linked diabetogenic susceptibility gene(s) in non-obese diabetic mice. J. Immunol. 163: 1721-1724.
15. FUJISAWA, T., H. IKEGAMI, Y. KAWAGUCHI et al. 1995. Class I HLA is associated with age-at-onset of IDDM, while class II HLA confers susceptibility to IDDM. Diabetologia 38: 1494-1496.
16. NEJENTSEV, S., Z. GOMBOS, A-P. LAINE et al. 2000. Non-class IIHLA gene associated with type 1 diabetes maps to the 240-kb region near HLA-B. Diabetes 49: 2217-2221.
17. SATOH, J., H. SEINO, T. ABO et al. 1989. Recombinant human tumor necrosis factor a suppresses autoimmune diabetes in nonobese diabetic mice. J. Clin. Invest. 84: 1345-1348.
18. JACOB, C.O., S. AISO, S. MICHIE et al. 1990. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1. Proc. Natl. Acad. Sci. USA 87: 968-972.
19. BABAYA, N., H. IKEGAMI, T. FUJISAWA et al. 2002. Sequence analysis of Tnf as a candidate for Idd16. Autoimmunity 35: 63-66.
20. LUND, T., S. SHAIKH, E. KENDALL et al. 1993. RFLP analysis of the MHC class III region defines unique haplotypes for the non-obese diabetic, cataract Shionogi and the non-obese non-diabetic mouse strains. Diabetologia 36: 727-733.
21. NISHIMOTO, H., H. KIKUTANI, K. YAMAMURA et al. 1987. Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice. Nature 328: 432-434.
22. nod/b heterozygote. J. Immunol. 142: 781-784.
23. TODD, J.A., T. AITMAN, R. CORNALL et al. 1991. Genetic analysis of autoimmune type 1 diabetes mellitus in mice. Nature 351: 542-547.
24. WICKER, L., J. TODD, J-B. PRINS et al. 1994. Resistance alleles at two non-major histocompatibility complex-linked insulin-dependent diabetes loci on chromosome 3, Idd3 and Idd10, protect nonobese diabetic mice from diabetes. J. Exp. Med. 180: 1705-1713.
25. PODOLIN, P., P. DENNY, C. LORD et al. 1997. Congenic mapping of the insulin-dependent diabetes (Idd) gene, Idd10, localizes two genes mediating the Idd10 effect and eliminate the candidate Fcgrl. J. Immunol. 159: 1835-1843.
26. PODOLIN, P., P. DENNY, N. ARMITAGE et al. 1998. Localization of two insulin-dependent diabetes (Idd) genes to the Idd10 region on mouse chromosome 3. Mamm. Genome 9: 283-286.
27. DENNY, P., C.J. LORD, N.J. HILL et al. 1997. Mapping of the IDDM locus Idd3 to 0.35 cM interval containing the interleukin-2 gene. Diabetes 46: 695-700.
28. LYONS, P., N. ARMITAGE, F. ARGENTINA et al. 2000. Congenic mapping of the type 1 diabetes locus, Idd3, to a 780-kb region of mouse chromosome 3: identification of a candidate segment of ancestral DNA by haplotype mapping. Genome Res. 10: 446-453.
29. GHOSH, S., S.M. PALMER, N.R. RODRIGUES et al. 1993. Polygenic control of autoimmune diabetes in nonobese diabetic mice. Nat. Genet. 4: 404-409.
30. PODOLIN, P.L., M.B. WILUSZ, R.M. CUBBON et al. 2000. Differential glycosylation of interleukin-2, the molecular basis for the NOD Idd3 type 1 diabetes gene? Cytokine 12: 477-482.
31. IKEGAMI, H., T. FUJISAWA, S. MAKINO et al. 2002. Genetic dissection of type 1 diabetes susceptibility gene, Idd3, by ancestral haplotype congenic mapping. Ann. N.Y. Acad. Sci. 958: 325-328.
32. IKEGAMI, H. & S. MAKINO. 2001. The NOD mouse and its related strains. In A Primer on Animal Models of Diabetes, pp. 43-62. Harwood Academic Pub. Amsterdam.
33. PARRISH-NOVAK, J., S.R. DILLON, A. NELSON et al. 2000. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408: 57-63.
34. PRINS, J-B., J.A. TODD, N.R. RODRIGUES et al. 1993. Linkage on chromosome 3 of autoimmune diabetes and defective Fc receptor for IgG in NOD mice. Science 260: 695-698.